Koppel Adam insider trades
Koppel Adam has filed 16 Form 4s with the SEC that we hold, for CERE (Director, 10% owner), Foghorn Therapeutics Inc. (FHTX) (Director), Solid Biosciences Inc. (SLDB) (Director, 10% owner) and APTX (Director, 10% owner), among 6 companies in all. Across all of them we count 2 purchases worth $150.0M and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($25.0M) and 0 sales ($0). The largest single trade was a purchase of 5,480,052 shares of CERE worth $125.0M, dated 2023-10-16. The first filing on our record is dated 2021-07-14 and the latest 2026-04-20.
CERE
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-10-16 | P, purchase reported on Form 4 | 5,480,052 | $125.0M | 2023-10-18 |
Foghorn Therapeutics Inc. (FHTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Solid Biosciences Inc. (SLDB)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
APTX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
DRNA
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Kailera Therapeutics, Inc. (KLRA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-04-20 | P, purchase reported on Form 4 | 1,562,500 | $25.0M | 2026-04-20 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1578965) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms